多西他赛或表皮生长因子受体酪氨酸激酶抑制剂二线治疗晚期非小细胞肺癌的临床观察
张琴,周韶璋,黄明月,戴辉,葛莲英
Docetaxel versus EGFR-TKIs as second-line treatment in patients with advanced non-small cell lung cancer
ZHANG Qin,ZHOU Shaozhang,HUANG Mingyue,DAI Hui,GE Lianying
中国癌症防治杂志
.
2015, (2): 94
-99
.
DOI: 10.3969/j.issn.1674-5671.2015.02.06
